Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of health-system pharmacy 2020-05, Vol.77 (11), p.835-864
Hauptverfasser:	Rybak, Michael J, Le, Jennifer, Lodise, Thomas P, Levine, Donald P, Bradley, John S, Liu, Catherine, Mueller, Bruce A, Pai, Manjunath P, Wong-Beringer, Annie, Rotschafer, John C, Rodvold, Keith A, Maples, Holly D, Lomaestro, Benjamin M
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Kidney Injury - chemically induced Acute Kidney Injury - prevention & control Anti-Bacterial Agents - adverse effects Anti-Bacterial Agents - pharmacokinetics Anti-Bacterial Agents - pharmacology Anti-Bacterial Agents - therapeutic use Area Under Curve Drug Monitoring Humans Microbial Sensitivity Tests Practice Guidelines as Topic Staphylococcal Infections - drug therapy United States Vancomycin - adverse effects Vancomycin - pharmacokinetics Vancomycin - pharmacology Vancomycin - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!